HALP as a Novel Score for Prediction of Mortality and re_bleeding in Upper GIT Bleeding

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSohag University

About this trial

Evaluation of the prognostic utility of the HALP score in patients with upper gastrointestinal bleeding, particularly in predicting re\_bleeding risk and mortality in internal medicine department in Sohag University Hospitals.

Eligibility criteria

Qualifiers

Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.

Disqualifiers

Incomplete clinical data.

Lack of laboratory results obtained at emergency department admission necessary for the calculation of HALP score; albumin, hemoglobin (HGB), platelets (PLT), or international normalized ratio (INR).

Pregnancy

Patients with missing data on clinical outcomes

Trial design

Treatments tested in this trial

  • Upper endoscopy

Treatment groups

No treatment groups listed

Sponsors and collaborators